Relationship between impaired cardiac sympathetic activity and spatial dyssynchrony in patients with non-ischemic heart failure: Assessment by MIBG scintigraphy and tagged MRI

Journal of Nuclear Cardiology

Volumn 20, Issue 4, 2013, Pages 600-608

  Yonezawa, Masato ^a   Nagao, Michinobu ^a   Abe, Koichiro ^a   Matsuo, Yoshio ^a   Baba, Shingo ^a   Kamitani, Takeshi ^a   Isoda, Takuro ^a   Maruoka, Yasuhiro ^a   Jinnouchi, Mikako ^a   Yamasaki, Yuzo ^a   Abe, Kohtaro ^a   Higo, Taiki ^a   Yoshiura, Takashi ^a   Honda, Hiroshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

dyssynchrony; Heart failure; MIBG; sympathetic activity; tagging MRI

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC SYMPATHETIC ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICULAR DYSSYNCHRONY; HEART SCINTISCANNING; HEART TO MEDIASTINUM RATIO; HUMAN; INCIDENCE; ISOTOPE LABELING; LEFT VENTRICULAR ASSIST DEVICE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QRS COMPLEX; RADIOISOTOPE DISTRIBUTION; RADIOLOGICAL PARAMETERS; SYMPATHETIC TONE;

3-IODOBENZYLGUANIDINE; ADOLESCENT; ADULT; AGED; CARDIAC RESYNCHRONIZATION THERAPY; FEMALE; HEART; HEART FAILURE; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; IODINE RADIOISOTOPES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; YOUNG ADULT;

EID: 84880142671     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-013-9715-1     Document Type: Article

References (35)

1. Bohm M, La Rosee K, Schwinger RH, Erdmann E. Evidence for reduction of norepinephrine uptake sites in the failing human heart. J Am Coll Cardiol 1995;25:146-53.
2. Manger WM, Hoffman BB. Heart imaging in the diagnosis of pheochromocytoma and assessment of catecholamine uptake. J Nucl Med 1983;24:1194-6. (Pubitemid 14218718)
3. Glowniak JV, Turner FE, Gray LL, Palac RT, Lagunas-Solar MC, Woodward WR. Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants. J Nucl Med 1989;30:1182-91. (Pubitemid 19175977)
4. Merlet P, Pouillart F, Dubois-Rande JL, Delahaye N, Fumey R, Cataigne A, et al. Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart. J Nucl Med 1999;40:224-31. (Pubitemid 29077082)
5. Schofer J, Spielmann R, Schuchert A, Weber K, Schluter M. Iodine-123 meta-iodobenzylguanidine scintigraphy: A noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1988;12:1252-8.
6. Agostini D, Verberne HJ, Burchert W, Knuuti J, Povinec P, Sambuceti G, et al. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: Insights from a retrospective European multicenter study. Eur J Nucl Med Mol Imaging 2008;35:535-46.
7. Merlet P, Benvenuti C, Moyse D, Pouillart F, Dubois-Rande JL, Duval AM, et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 1999;40:917-23. (Pubitemid 29269210)
8. Nakata T, Miyamoto K, Doi A, Sasao H, Wakabayashi T, Kobayashi H, et al. Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts. J Nucl Cardiol 1998;5:579-90. (Pubitemid 29015414)
9. Kalra PR, Sharma R, Shamim W, Doehner W, Wensel R, Bolger AP, et al. Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration. Int J Cardiol 2002;86:225-31. (Pubitemid 35284812)
10. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011;124:2761-96.
11. Manolio TA, Baughman KL, Rodeheffer R, Pearson TA, Bristow JD, Michels VV, et al. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop. Am J Cardiol 1992;69:1458-66.
12. Mestroni L, Maisch B, McKenna WJ, Schwartz K, Charron P, Rocco C, et al. Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur Heart J 1999;20:93-102. (Pubitemid 29048080)
13. Okin PM, Devereux RB, Nieminen MS, Jerm S, Oikarinen L, Viltasaio M, et al. Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients. Hypertension 2004;44:48-54. (Pubitemid 38823486)
14. Topol EJ, Traill TA, Fortuin NJ. Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med 1985;312:277-83. (Pubitemid 15199366)
15. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009;34:1219-63.
16. Arts T, Prinzen FW, Delhaas T, Milles JR, Rossi AC, Clarysse P. Mapping displacement and deformation of the heart with local sine-wave modeling. IEEE Trans Med Imaging 2010;29:1114-23.
17. Fornwalt BK, Arita T, Bhasin M, Voulgaris G, Merlino JD, Leon AR, et al. Cross-correlation quantification of dyssynchrony: A new method for quantifying the synchrony of contraction and relaxation in the heart. J Am Soc Echocardiogr 2007;20:1330 e1-1337 e1.
18. Manrique A, Bernard M, Hitzel A, Bauer F, Menard JF, Sabatier R, et al. Prognostic value of sympathetic innervation and cardiac asynchrony in dilated cardiomyopathy. Eur J Nucl Med Mol Imaging 2008;35:2074-81.
19. Tanaka H, Tatsumi K, Fujiwara S, Tsuji T, Kaneko A, Ryo K, et al. Effect of left ventricular dyssynchrony on cardiac sympathetic activity in heart failure patients with wide QRS duration. Circ J 2012;76:382-9.
20. Lardo AC, Abraham TP, Kass DA. Magnetic resonance imaging assessment of ventricular dyssynchrony: Current and emerging concepts. J Am Coll Cardiol 2005;46:2223-8. (Pubitemid 41785489)
21. Epstein FH. MRI of left ventricular function. J Nucl Cardiol 2007;14:729-44. (Pubitemid 47355088)
22. Osman NF, Prince JL. Visualizing myocardial function using HARP MRI. Phys Med Biol 2000;45:1665-82. (Pubitemid 30408925)
23. Nagao M, Hatakenaka M, Matsuo Y, Kamitani T, Higuchi K, Shikata F, et al. Subnedocardial contractile impairment in chronic ischemic myocardium: Assessment by strain analysis of 3T tagged CMR. J Cardiovasc Magn Reson 2012;14:14.
24. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 2010;55:2212-21.
25. Podrid PJ, Fuchs T, Candinas R. Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. Circulation 1990;82:I103-13.
26. Zipes DP. Sympathetic stimulation and arrhythmias. N Engl J Med 1991;325:656-7.
27. Nishisato K, Hashimoto A, Nakata T, Doi T, Yamamoto H, Nagahara D, et al. Impaired cardiac sympathetic innervation and myocardial perfusion are related to lethal arrhythmia: Quantification of cardiac tracers in patients with ICDs. J Nucl Med 2010;51:1241-9.
28. Inoue Y, Yang X, Nagao M, Higashino H, Hosokawa K, Kido T, et al. Peri-infarct dysfunction in post-myocardial infarction: Assessment of 3-T tagged and late enhancement MRI. Eur Radiol 2010;20:1139-48.
29. Adelstein EC, Tanaka H, Soman P, Miske G, Haberman SC, Sabe SF, et al. Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy. Eur Heart J 2011;32:93-103.
30. Stahlberg M, Braunschweig F, Gadler F, Karlsson H, Linde C. Three year outcome of cardiac resynchronization therapy: A single center evaluation. Pacing Clin Electrophysiol 2005;28:1013-7. (Pubitemid 43951402)
31. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53. (Pubitemid 34603028)
32. Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P, et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 2004;44:1834-40. (Pubitemid 39424084)
33. Nishioka SA, Martinelli Filho M, Brandao SC, Giorgi MC, Vieira ML, et al. Cardiac sympathetic activity pre and post resynchronization therapy evaluated by 123I-MIBG myocardial scintigraphy. J Nucl Cardiol 2007;14:852-9. (Pubitemid 350082581)
34. Higuchi K, Toyama T, Tada H, Naito S, Ohshima S, Kurabayashi M. Usefulness of biventricular pacing to improve cardiac symptoms, exercise capacity and sympathetic nerve activity in patients with moderate to severe chronic heart failure. Circ J 2006;70:703-9. (Pubitemid 43797781)
35. Pitzalis MV, Iacoviello M, Romito R, Massari F, Rizzon B, Luzzi G, et al. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol 2002;40:1615-22. (Pubitemid 35253639)